Big News: FDA is moving from MasterControl to ComplianceQuest.See Why
Talk to a SpecialistLoading…
Talk to a SpecialistTalk to a Specialistcheaptrustedpharmacy.com, an online pharmacy based in Turks & Caicos Islands, was cited for unlawfully selling unapproved and misbranded drugs to U.S. consumers in violation of the Federal Food, Drug, and Cosmetic Act (sections 301(a), 301(d), 503(b), and 505(a)). The company offered dangerous drug products including opioids, semaglutide injectables, drugs subject to Risk Evaluation and Mitigation Strategy (REMS) programs, and medications indicated for serious conditions like HIV/AIDS and cancer—all without FDA approval or proper labeling. The FDA emphasized that unapproved drugs bypass regulatory safeguards and pose severe risks including contamination, counterfeiting, variable active ingredient amounts, and in the case of injectables, life-threatening infections such as septicemia or sepsis. The agency requested the company immediately cease offering all unapproved and misbranded drugs to U.S. consumers to protect public health.